DSO National Laboratories from Singapore and IB Consultancy are proud to announce that the 2017 editions of SISPAT and NCT will be held in conjunction at the Marina Bay Sands Singapore on 21-23 March 2017. The 8th edition of SISPAT will again be the premier scientific forum in the field of CBRN. The 24th and 25th editions of the NCT CBRNe Asia and eXplosive Asia conferences will continue to be the main forum for CBRN and C-IED/EOD professionals in the Asian region. During the three-day event, the three conferences will have one shared exhibition showcasing the latest equipment from the global CBRN and C-IED/EOD industries.
Dr. Ronald Hann, Director of the Chemical/Biological Technologies Department at the Defense Threat Reduction Agency, has been confirmed as a speaker for the joint closing plenary of NCT Asia & SISPAT 2017. Before his current position…Read more
The Director-General of the OPCW, H.E. Mr Ahmet Üzümcü, will give a keynote speech during the opening plenary of NCT Asia & SISPAT 2017 alongside Mr. Quek Gim Pew of Singapore's Ministry of Defence and Mr.…Read more
Presentations that fall within the general objectives of the 8th edition of the Singapore International Symposium for Protection Against Toxic Substances (SISPAT) are invited. The abstract requirement and submission guidelines can be found at the SISPAT Call for Papers page. All contributions…Read more
Bruker Detection is a leading global specialist producing Chemical Biological Radiation Nuclear Explosive detection equipment and total solutions. Widely regarded as the development and manufacturing expert of easy to use and reliable instruments, our product line ranges from handheld to stand-off detectors and complete solutions for platform integration. We understand that complex scenarios require an integrated system approach and as one of the most experienced players on the market we can provide the right answers. Bruker – Innovation with Integrity!Bruker Detection
Heyltex Corporation specializes in the development, manufacturing & international distribution of medical countermeasures for radiological public health emergencies. In cooperation with Heyl chem. pharm. Fabrik Berlin, Heyltex has developed Radiogardase®, an antidote against Cesium-137 which is the only antidote against Cesium-137 approved by the U.S. Food and Drug Administration. Ca-DTPA, Zn-DTPA and other chelating agents are also part of our portfolio. Heyltex’ newly launched product, eventPOD™, aims to bring antidotes together in a module which temporarily increases medical preparedness of organizers of High Visibility Events (HVE).Heyltex